Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 118,420 | 78,345 | 49,622 | 51,617 | 99,107 |
| Receivables | 776,215 | 756,634 | 778,638 | 670,476 | 614,687 |
| Inventories | 612,454 | 596,359 | 575,624 | 570,653 | 581,384 |
| TOTAL | $1,587,806 | $1,513,294 | $1,485,480 | $1,380,044 | $1,377,863 |
| Non-Current Assets | |||||
| PPE Net | 424,908 | 431,020 | 425,380 | 439,815 | 447,574 |
| Intangibles | 1,329,813 | 1,378,513 | 1,418,477 | 1,457,821 | 1,489,052 |
| Other Non-Current Assets | 158,918 | 138,151 | 180,585 | 178,717 | 158,080 |
| TOTAL | $1,913,639 | $1,947,684 | $2,024,442 | $2,076,353 | $2,094,706 |
| Total Assets | $3,501,445 | $3,460,978 | $3,509,922 | $3,456,397 | $3,472,569 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 324,213 | 364,692 | 435,519 | 212,660 | 213,125 |
| Accounts payable and accrued liabilities | 757,761 | 684,007 | 631,967 | 575,593 | 541,983 |
| Other current liabilities | 31,755 | 30,181 | 30,740 | 30,130 | 76,988 |
| TOTAL | $1,129,771 | $1,095,209 | $1,114,353 | $834,388 | $846,595 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,161,790 | 2,169,607 | 2,177,578 | 2,419,600 | 2,427,451 |
| Other Non-Current Liabilities | 252,168 | 277,816 | 264,687 | 256,073 | 173,207 |
| TOTAL | $2,481,186 | $2,459,336 | $2,453,058 | $2,685,638 | $2,605,963 |
| Total Liabilities | $3,610,957 | $3,554,545 | $3,567,411 | $3,520,026 | $3,452,558 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 309,966 | 309,844 | 309,543 | 308,651 | 307,007 |
| Common Shares | 3,099 | 3,098 | 3,095 | 3,086 | 3,066 |
| Retained earnings | -607,062 | -575,981 | -575,825 | -581,819 | -490,176 |
| Other shareholders' equity | -65,755 | -73,917 | -30,460 | -23,616 | -32,119 |
| TOTAL | $-109,512 | $-93,567 | $-57,489 | $-63,629 | $20,011 |
| Total Liabilities And Equity | $3,501,445 | $3,460,978 | $3,509,922 | $3,456,397 | $3,472,569 |